| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |